Inside the research
iShares Biotechnology ETF
IBB Research profile · latest available data
Price overview
$209.77
▲ +0.52 (+0.2%)
| 52w hi | $216.95 |
|---|---|
| 52w lo | $138.79 |
| Vol | 1.28M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.01
| Short | +0.38 |
|---|---|
| Medium | -0.04 |
| Long | -0.64 |
computed 2026-09-27
Key fundamentals
iShares Biotechnology ETF
| Trailing P/E | 26.21x |
|---|
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.07 | |
| Sector | — | |
| Technical | +0.19 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Risk Metrics
| Beta vs SPX | 0.81 |
|---|---|
| Corr SPX | 0.57 |
| Annual vol | 22.6% |
| Annual ret | +20.0% |
| Sharpe | 0.88 |
| Max DD | -24.7% |
Window: 504 trading days (504 obs)
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $209.75 | $210.25 | $207.62 | $209.77 | 1.28M |
| Sep 24 | $206.00 | $209.52 | $205.63 | $209.25 | 1.60M |
| Sep 23 | $211.23 | $211.83 | $205.66 | $206.60 | 1.84M |
| Sep 22 | $207.74 | $211.64 | $207.20 | $210.81 | 1.52M |
| Sep 21 | $205.71 | $208.09 | $204.24 | $207.16 | 1.72M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →